Inhibition of human immunodeficiency virus type-1 by cdk inhibitors - Wikidata - wikimedia - TriplyDB

Inhibition of human immunodeficiency virus type-1 by cdk inhibitors

Inhibition of human immunodeficiency virus type-1 by cdk inhibitors

http://www.wikidata.org/entity/Q33780297

about

Systems Biology-Based Investigation of Cellular Antiviral Drug Targets Identified by Gene-Trap Insertional Mutagenesis Machine learning methods for prediction of CDK-inhibitors Purvalanol A, olomoucine II and roscovitine inhibit ABCB1 transporter and synergistically potentiate cytotoxic effects of daunorubicin in vitro Drug-Based Lead Discovery: The Novel Ablative Antiretroviral Profile of Deferiprone in HIV-1-Infected Cells and in HIV-Infected Treatment-Naive Subjects of a Double-Blind, Placebo-Controlled, Randomized Exploratory Trial Alteration in superoxide dismutase 1 causes oxidative stress and p38 MAPK activation following RVFV infection Studies on quantitative phosphopeptide analysis by matrix-assisted laser desorption/ionization mass spectrometry without label, chromatography or calibration curves Inhibition of post-transcriptional RNA processing by CDK inhibitors and its implication in anti-viral therapy.Select host restriction factors are associated with HIV persistence during antiretroviral therapy.Use of ATP analogs to inhibit HIV-1 transcription.Inhibition of Tat-mediated HIV-1 replication and neurotoxicity by novel GSK3-beta inhibitors.Ebola VP40 in Exosomes Can Cause Immune Cell Dysfunction.The phosphorylation of HIV-1 Gag by atypical protein kinase C facilitates viral infectivity by promoting Vpr incorporation into virions.Novel neuroprotective GSK-3β inhibitor restricts Tat-mediated HIV-1 replication.Kinase control of latent HIV-1 infection: PIM-1 kinase as a major contributor to HIV-1 reactivation.Cellular kinases incorporated into HIV-1 particles: passive or active passengers?Strategies to Block HIV Transcription: Focus on Small Molecule Tat Inhibitors.Case-management of malaria in children attending an outpatient clinic in southwest Nigeria.Targeting of CDK9 with indirubin 3'-monoxime safely and durably reduces HIV viremia in chronically infected humanized mice.Repurposing of Kinase Inhibitors as Broad-Spectrum Antiviral Drugs.Development of psychotherapy. Establishment of the International Federation for Psychotherapy (IFP) and other organizations.

P2860

Q27468694-08FCA82E-ACB6-4124-8735-C3C1C811F656 Q28475771-82B21EB8-034E-4938-938E-B561A5B94832 Q28537944-ECEAE65A-37A3-40DF-9E84-DD9F3B49CDA9 Q28552171-5CB6C6F6-8BC7-435C-8950-C525AEB896D1 Q33927167-7A7AB58B-5C0B-4A66-9074-8484F2B02830 Q34477921-8B7FAF01-C65E-4210-BFDA-5D9F065A91D9 Q35106892-1DC38688-8097-436C-8C7F-B5F906687FE2 Q35271996-EAED4C57-FA3A-4B80-8E6F-27054C87498D Q36202709-4B24FC3A-018B-493D-AFDC-EEE116A6A332 Q36915824-A886807C-F21F-4E4A-ADB3-47854B1E71B7 Q37397177-B8A0F6E2-A26D-40A1-8519-6933EE4C7B50 Q37528045-AB7D13AD-1078-482A-95AD-744B7A936498 Q37547409-9CDC69DE-DE7A-43D6-8798-8DE344ED13A8 Q37547710-69FA67E5-891D-4EBF-8C25-F3CA2B6531E3 Q37925860-E7B535DA-B49F-448E-9720-A12A2756B9C6 Q38212101-F04D855A-A9D9-4205-8001-1CECA00DC9DF Q38458917-838894F9-158F-4BC0-AD6C-88137810536D Q40079572-6FEBDF59-9738-44D5-97C2-7833FDA99F6F Q46916610-B3A313F5-587F-4C0E-9F23-9495BFF69AD0 Q48462323-6E376EA1-2D31-416B-8A5B-65233493CFCA

P2860

Inhibition of human immunodeficiency virus type-1 by cdk inhibitors

http://www.wikidata.org/entity/Q33780297

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Inhibition of human immunodeficiency virus type-1 by cdk inhibitors

@ast

Inhibition of human immunodeficiency virus type-1 by cdk inhibitors

@en

type

label

Inhibition of human immunodeficiency virus type-1 by cdk inhibitors

@ast

Inhibition of human immunodeficiency virus type-1 by cdk inhibitors

@en

prefLabel

Inhibition of human immunodeficiency virus type-1 by cdk inhibitors

@ast

Inhibition of human immunodeficiency virus type-1 by cdk inhibitors

@en

P1433

Q33780297-E291F187-7D42-4009-B9D4-57975C76035C

P1476

Q33780297-4AA55D5C-95A9-419E-ACF2-59F2FDA65BF4

P2093

Q33780297-25FF53F2-9F7A-4DDA-9291-568496DC6127

Q33780297-9D5EDC8D-69E0-463B-905E-823F8885367D

Q33780297-B230C7C0-53D0-499D-9842-17BC818ED8EB

P2860

Q33780297-04A1A7A7-7BEA-4925-A004-99E08C3D8968

Q33780297-0714FC7F-8361-48FF-B6CB-CF43BF5A7D41

Q33780297-0BDC7E1B-C51E-4205-A44E-C840FC542937

Q33780297-0CD32EDB-0CBD-4DD4-A358-108A22CC3019

Q33780297-0EC4EC32-6277-4AED-B28F-8534C865A28F

Q33780297-0F63BC89-036D-47C3-A551-734203E8705E

Q33780297-15335CA9-DEA6-49C3-AA01-68002B01791B

Q33780297-17F47CF0-7917-476E-B043-91317CBD01E8

Q33780297-184F0700-9464-4D66-A0E8-ED0C40E061A4

Q33780297-1AA07FCF-E78E-48BC-98EF-1351D35947A3

P2888

Q33780297-BC50286E-EEAD-407F-BD60-EBA3C9C9FD79

P304

Q33780297-E23CE3A0-93E0-4294-8B74-F9DE628314FF

P31

Q33780297-5DC0E69D-E68B-4280-A99A-BF8CD1EDA9E2

P356

Q33780297-5E69BD75-03E1-4ED0-B5E8-706A5E8CE5BF

Q33780297-91791CCD-802A-4413-A7E8-F7B406CD2962

P433

Q33780297-1EFA7AC9-9163-47CA-9D48-42AA14E0B80E

P478

Q33780297-4A4262B1-0DD3-460B-84DD-2393FDDEA8EE

P50

Q33780297-0243728F-AB23-4E3A-838D-CE0677158CBF

P577

Q33780297-1BC6B701-E3F2-45B2-87A2-5CCB0A6E22EB

P6179

Q33780297-87ECA21E-B6E2-4CC1-B455-B70C6BFED002

P698

Q33780297-B6AE6CAB-950E-41D1-87AA-5A2C2D7DDD62

P921

Q33780297-702010C4-94E6-410A-839C-09E02F6586F7

P932

Q33780297-AE7248B6-C5D4-4633-B2D0-20BFED1BE831

P356

P1433

AIDS Research and Therapy

P1476

Inhibition of human immunodeficiency virus type-1 by cdk inhibitors

@en

P2093

Emmanuel T Agbottah

http://www.w3.org/2001/XMLSchema#string

Fatah Kashanchi

http://www.w3.org/2001/XMLSchema#string

Irene Guendel

http://www.w3.org/2001/XMLSchema#string

P2860

Impact of artemisinin-based combination therapy and insecticide-treated nets on malaria burden in Zanzibar

Phosphorylation of serine 468 by GSK-3beta negatively regulates basal p65 NF-kappaB activity

CDK9 autophosphorylation regulates high-affinity binding of the human immunodeficiency virus type 1 tat-P-TEFb complex to TAR RNA

Roscovitine inhibits activation of promoters in herpes simplex virus type 1 genomes independently of promoter-specific factors

Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: candidate for a Tat cofactor

GSK-3-selective inhibitors derived from Tyrian purple indirubins

Tat modifies the activity of CDK9 to phosphorylate serine 5 of the RNA polymerase II carboxyl-terminal domain during human immunodeficiency virus type 1 transcription

Potential use of pharmacological cyclin-dependent kinase inhibitors as anti-HIV therapeutics

A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA

Requirement for TFIIH kinase activity in transcription by RNA polymerase II

P2888

P304

7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1742-6405-7-7

http://www.w3.org/2001/XMLSchema#string

10.2217/THY.09.94

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Kylene Kehn-Hall

P577

2010-03-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1009590459

http://www.w3.org/2001/XMLSchema#string

P698

20334651

http://www.w3.org/2001/XMLSchema#string

P921

P932

2852372

http://www.w3.org/2001/XMLSchema#string